MEMO’s abstract has been accepted for Poster Discussion presentation during the ESMO Symposium on Immuno-Oncology – Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies, 4-6 November 2016, Lausanne, Switzerland.